abstract |
The present invention relates to a new kinase inhibitor, which is a compound of formula 1. It has been discovered that compounds of formula 1 are effective inhibitors of protein kinases, including members of the PDGFR and VEGFR families, where the substituent R is disclosed in the claims. |